ASX Share rice
Tue 18 May 2021 - 12:08:pm (Sydney)

ACR Share Price

ACRUX LIMITEDACRPharmaceuticals, Biotechnology & Life Sciences

ACR Company Information

Name:

Acrux Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Pharmaceuticals

GIC Sub Industry:

Pharmaceuticals

Address:

103-113 Stanley Street West Melbourne VIC Australia 3003

Phone:

61 3 8379 0100

CEO, MD & Exec. Director:

Mr. Michael John Kotsanis B.Sc., BSc, GradDipBus, MBus

CFO & Company Sec.:

Ms. Deborah Ambrosini

Company Overview:

Acrux Limited, together with its subsidiaries, develops and commercializes generic and specialty topical pharmaceuticals in Australia, Germany, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. Acrux Limited was founded in 1998 and is based in West Melbourne, Australia.

ACR Share Price Information

Shares Issued:

282.44M

Market Capitalisation:

$39.54M

Dividend per Share:

$0.06

Ex Dividend Date:

2015-08-18

Dividend Yield:

42.86%

Revenue (TTM):

$1.61M

Revenue Per Share (TTM):

$0.01

Earnings per Share:

$-0.05

Operating Margin (TTM):

$-8.71

Return On Assets (TTM):

$-0.46

Return On Equity (TTM):

$-0.78

Quarterly Revenue Growth (YOY):

0.807

Gross Profit(TTM):

$-3,759,000

Diluted Earnings Per Share (TTM):

$-0.063

ACR CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-254,000

Change To Liabilities:

$92K

Total Cashflow From Investing Activities:

$-254,000

Net Borrowings:

$-159,000

Net Income:

$-9,471,000

Total Cash From Operating Activities:

$-8,533,000

Depreciation:

$601K

Other Cashflow From Investing Activities:

$4K

Change To Account Receivables:

$-246,000

Capital Expenditures:

$258K

ACR Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-9,385,000

Net Income:

$-9,471,000

Gross Profit:

$1.25M

Operating Income:

$-9,385,000

Other Operating Expenses:

$1.23M

Income Tax Expense:

$86K

Total Revenue:

$3.95M

ACR Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$589K

Total Liabilities:

$4.99M

Total Stockholder Equity:

$12.85M

Other Current Liabilities:

$853K

Total Assets:

$17.84M

Common Stock:

$96.14M

Retained Earnings:

$-83,870,000

Other Liabilities:

$88K

Other Assets:

$2.39M

Cash:

$9.21M

Total Current Liabilities:

$2.67M

Property - Plant & Equipment:

$3.10M

Net Tangible Assets:

$12.85M

Total Current Assets:

$12.34M

Net Receivables:

$2.56M

Short-Term Investments:

$5.49M

Accounts Payable:

$1.03M

Short-Term Investments:

$5.49

Non Current Liabilities Total:

$2.32M

ACR Share Price History

ACR News

26 Feb, 2021
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
28 Nov, 2020
Michael Kotsanis became the CEO of Acrux Limited (ASX:ACR) in 2014, and we think it's a good time to look at the...
31 Aug, 2020
Just because a business does not make any money, does not mean that the stock will go down. For example, although...

ACR Dividend Payments

EX-Date Dividend Amount
2011-03-31$0.6000
2012-09-04$0.0800
2013-09-03$0.0800
2014-02-25$0.1200
2014-09-04$0.0800
2015-08-18$0.0600

ACR Dividends (last 5 Years)